Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis

dc.contributor.authorNas, Kemal
dc.contributor.authorKarkucak, Murat
dc.contributor.authorDurmus, Bekir
dc.contributor.authorKaratay, Saliha
dc.contributor.authorCapkin, Erhan
dc.contributor.authorKaya, Arzu
dc.contributor.authorUcmak, Derya
dc.date.accessioned2024-04-24T17:11:24Z
dc.date.available2024-04-24T17:11:24Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractAimPsoriatic arthritis (PsA) is a chronic, inflammatory disease. The purpose of this study was to examine the association between PsA and comorbid conditions. This is the first study to investigate comorbid diseases in PsA in Turkey. MethodsThis study was performed under the auspices of the Anatolian Group for the Assessment in Rheumatic Diseases (ANGARD) and involved participation by six university research hospitals. Patients diagnosed with and treated for PsA on the basis of clinical, radiological and laboratory findings and expert opinion were monitored using standardized examination methods and jointly prepared forms. Clinical status, accompanying systemic diseases and surgical history were recorded. ResultsOne hundred and seventy-three patients with PsA (75 male, 98 female, mean age 41.8) and 138 patients with rheumatoid arthritis (RA) (17 male, 121 female, mean age 48.6) and 67 with psoriasis (PsO) (43 male, 24 female, mean age 36.1) were included in the study. No accompanying disease was determined in 72.8% of PsA, 50.0% of RA and 80.6% of PsO groups. In regression analysis, patients with PsA had higher risk for cataract/glaucoma surgery (odds ratio [OR]=11.99; 95% CI 1.36-105.4, P=0.025) compared to patients with RA, and higher risk for hypertension (HT) (OR=4.26; 95% CI 1.27-14.23, P=0.018) compared to the patients with PsO. ConclusionPatients with PsA have relatively lower frequency of comorbidities like diabetes mellitus, HT and cataract/glaucoma surgery compared to the patients with RA. The increased risk for having cataract/glaucoma surgery in RA compared to PsA may be particularly attributed to the more prevalent glucocorticoid use in RA.en_US
dc.identifier.doi10.1111/1756-185X.12580
dc.identifier.endpage879en_US
dc.identifier.issn1756-1841
dc.identifier.issn1756-185X
dc.identifier.issue8en_US
dc.identifier.pmid26173043
dc.identifier.scopus2-s2.0-84954313535
dc.identifier.scopusqualityQ3
dc.identifier.startpage873en_US
dc.identifier.urihttps://doi.org/10.1111/1756-185X.12580
dc.identifier.urihttps://hdl.handle.net/11468/17477
dc.identifier.volume18en_US
dc.identifier.wosWOS:000369524700010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofInternational Journal of Rheumatic Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComorbid Diseasesen_US
dc.subjectPsoriasisen_US
dc.subjectPsoriatic Arthritisen_US
dc.subjectRheumatoid Arthritisen_US
dc.titleComorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasisen_US
dc.titleComorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
dc.typeArticleen_US

Dosyalar